Real World Experience

Russo Partners has a history. From the evolution of biotech to the launch of pharmaceutical marketing 2.0, we have been there every step of the way.

We’re not all talk. PR isn’t just about getting a message out. It’s getting the right message to the right people at the right time. At Russo Partners, we do just that – and so much more.

Home

Introducing our new Sports-Health Alliance.

We develop award-winning PR programs that are at the intersection of health, medicine, and sports. We call on our cadre of athletes, broadcasters and sports business leaders with whom we have close relationships and share the passions of our clients

Learn more about how this strategic approach is shifting perceptions of our clients and their products, fueling their clinical trial enrollment, and doing much, much more

 

At Russo Partners, communications counselors with PhDs, MDs, JDs and MBAs roll up their sleeves to implement integrated programs for biopharma, medtech, diagnostics, healthcare IT and healthcare services companies worldwide.

Since our founding as Noonan/Russo more than 25 years ago, we’ve been on a first-name basis with the people you need to be talking to. Which means you should be talking to us.

Latest News

 

May
29

Curis Announces Effectiveness of 1-for-5 Reverse Stock Split

LEXINGTON, Mass., May 29, 2018 /PRNewswire/ — Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development and commercialization of innovative andREAD MORE…

May
15

Immunexpress Strengthens Board of Directors with Key Appointments

SEATTLE, May 15, 2018 /PRNewswire/ — Immunexpress, Inc. today announced the appointment of three new members to its Board of Directors. Rolland Carlson, PhD, Tanja Dowe and KatleenREAD MORE…

May
14

PolarityTE Acquires Operating GLP/USDA Preclinical Biomedical Research Facility and Announces Caroline Garrett DVM from Johns Hopkins as Chief Veterinary Officer at Polarity

SALT LAKE CITY, May 14, 2018 (GLOBE NEWSWIRE) — PolarityTE™, Inc. (NASDAQ:COOL) announced the acquisition of a preclinical biomedical researchREAD MORE…

Twitter Stream